Skin and Stem Cell Research Center, Tehran, Iran
Case Report
Treatment of Cutaneous Lymphoid Hyperplasia with Rituximab: A Case Report of 3 Patients
Author(s): Marzieh Matin, Ali Asilian, Samaneh Mozafar Poor, Elaheh Haftbaradaran* and Amir Feily
Benign Cutaneous Lymphoid Hyperplasia (CLH) is a B-cell pseudolymphoma of an unknown origin. The face is the most affected site in CLH. This report presents the cases of 3 patients with CLH who were treated with rituximab.
It is a hypothesis that rituximab is useful for treating resistant-to-relapsing forms of CLH that do not respond to previous therapies but must be checked with appropriate designs research. .. View More»
DOI:
10.35248/2684-124X.19.4.150
